SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001731122-22-001011
Filing Date
2022-05-27
Accepted
2022-05-27 16:30:48
Documents
12
Period of Report
2022-05-24
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e3801_8-k.htm   iXBRL 8-K 33766
  Complete submission text file 0001731122-22-001011.txt   205828

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE avxl-20220524.xsd EX-101.SCH 2953
3 XBRL LABEL FILE avxl-20220524_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE avxl-20220524_pre.xml EX-101.PRE 22355
6 EXTRACTED XBRL INSTANCE DOCUMENT e3801_8-k_htm.xml XML 3593
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37606 | Film No.: 22978124
SIC: 2836 Biological Products, (No Diagnostic Substances)